The detection of ductal carcinoma in situ at mammographic screening enables the diagnosis of small, grade 3 invasive tumours. by Evans, A. J. et al.
British Journal ofCancer(1997) 75(4), 542-544
© 1997 Cancer Research Campaign
The detection of ductal carcinoma in situ at
mammographic screening enables the diagnosis of
small, grade 3 invasive tumours
AJ Evans, SE Pinder, DRJ Snead, ARM Wilson, 10 Ellis and CW Elston
Departments of Radiology and Pathology, Nottingham City Hospital, Nottingham, UK
Summary This study was carried out to assess the frequency of ductal carcinoma in situ (DCIS) occurring within and surrounding grade 3
invasive tumours and the effect of its detection on size and nodal stage of invasive carcinomas at mammographic detection. Grade 3 tumours
with either no associated DCIS or DCIS only within the invasive component were significantly larger in size than tumours with surrounding
DCIS (P<0.02) and were less likely to be under or equal to 10 mm in size (0% or 13% vs 30% respectively, P<0.02). Tumours with
mammographic calcification were more likely to be less than or equal to 10 mm in size than non-calcific tumours (32% vs 11% respectively,
P<0.05). This was because of the high frequency of tumours less than or equal to 10 mm in size in the linear/branching calcification group.
Tumours showing calcification without a mass also appear to be a group with good prognostic features, with a mean size of 13 mm, 33%
being 10 mm or less in size and only 17% being node positive. We have found that the presence of surrounding DCIS enables earlier
detection of grade 3 invasive carcinomas because of the presence of mammographically visible calcification. Detection of calcification
suggestive of DCIS should remain an important part of mammographic screening.
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INTRODUCTION
Breast cancer detected by mammographic screening has a higher
proportion of low-grade invasive carcinomas and ductal carci-
noma in situ (DCIS) than symptomatic breast cancer (Cowan et al,
1991; Klemi et al, 1992). This has led some to suspect a degree
of overdiagnosis, at least in the prevalent screening round, when
such excellent-prognosis tumours are most frequently found
(Anderson et al, 1986).
Tabar et al (1992a,b) have stressed the importance of detecting
small high-grade invasive tumours at mammographic screening.
This is because the prognosis ofgrade 3 tumours, ifdetected while
less than 10 mm in size, is excellent and may not be significantly
worse than the prognosis of small lower-grade tumours. It is
important that grade 3 tumours be detected while small, before
they present as either interval cancers or at subsequent screens at
large sizes and with a very poor prognosis (Tabar et al, 1992a).
The detection of small high-grade invasive tumours may therefore
be important in the reduction in breast cancer mortality achieved
by mammographic screening.
There is a strong association between the grade of DCIS and the
grade ofinvasive tumour arising from it (Lampejo et al, 1994). High-
grade DCIS, which is usually mammographically visible (Holland et
al, 1990; Evans et al, 1994a), as calcification is frequently associated
with high-grade invasive tumours. A previous study has shown calci-
fication to be a common feature of grade 3 screen-detected tumours
(De Nunzio et al, 1996). We therefore postulate that high-grade
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DCIS is commonly associated with grade 3 invasive tumours and
that the presence of surrounding DCIS manifesting as calcification
may aid the early diagnosis ofgrade 3 invasive tumours.
This study was carried out to assess the frequency of DCIS
occurring within and surrounding grade 3 invasive tumours and
the effect ofits detection on size and nodal stage ofinvasive carci-
nomas at mammographic detection. Grading of invasive cancers,
in this study, was performed using the Nottingham method (Elston
et al, 1991). This technique involves semiquantitive evaluation of
three morphological features: the percentage of tubule formation,
the degree ofnuclear pleomorphism and an accurate mitotic count
using a defined field area.
MATERIALS AND METHODS
The histopathology and mammographic findings of all patients
with screen-detected grade 3 invasive breast carcinomas between
1988 and 1994 were reviewed. Sixty-one patients were included
in the study. According to radiological opinion, the lesions were
classified as 38% malignant, 35% probably malignant, 23% inde-
terminate and 4% probably benign. Fifty (86%) of 58 fine-needle
aspiration cytologies performed were malignant, and seven(88%)
ofthe eight core-cut biopsies performed were malignant.
The presence ofa grade 3 invasive tumour was confirmed using
the Nottingham method (Elston et al, 1991), its histological type
established (Ellis et al, 1992) and its maximum invasive size
measured. The presence or absence of any associated DCIS was
ascertained and its histological subtype recorded (NHSBSP, 1995).
If DCIS was present, it was established whether the DCIS was
found only within 1 mm ofthe invasive tumour (minimal DCIS) or
whether there was DCIS surrounding the invasive tumour. This
classification was performed by two pathologists independently,
and there was agreement in 94% ofcases.
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Table 1 Histological size and nodal status of grade 3 tumours by associated DCIS
DCIS status Nodal stage
No. of Size range Median size Mean size No. of Stage 1 Stage 2 Stage 3 Stage2
grade 3 (mm) (mm) (mm) grade 3 tumours or 3
tumours (%) <10 mm (%)
No DCIS 13 (21) 13-35 20 20 0 7 3 2 5 (42)a
Minimal DCIS 15 (25) 10-30 21 20 2 (13) 8 5 1 6 (43)
Surrounding DCIS 33 (54) 1.5-33 14 15 10 (30) 23 7 2 9 (28)
aNumbers in parenthese are percentages.
Table 2 Histological size and nodal status of grade 3 tumours according to mammographic appearance
Nodal stage
Mammographic No. of Size range Median size Mean size No. of Stage 1 Stage 2 Stage 3 Stage 2
appearance grade 3 (mm) (mm) (mm) grade 3 tumours or 3
tumours (%) < 10 mm (%)
Granular/punctate calcification 11(18) 6-28 19 16 2 (18) 6 5 0 5 (43)a
Linear/branching calcification 14 (23) 1.5-33 12 15 6 (43) 10 3 1 4 (29)
All suspicious calcification 25 (42) 1.5-33 19 15 8 (32) 16 8 1 9 (36)
Calcification no mass 6 (10) 1.5-28 13 13 2 (33) 5 1 0 1 (17)
Calcification with mass 19 (32) 6-33 19 19 5 (26) 11 7 1 8 (42)
Mass without calcification 35 (58) 5-35 18 18 4 (11) 22 7 4 11(33)
aNumbers in parentheses are percentages.
Lymph node stage was assessed by histological examination of
surgical axillary node sampling and internal mammary node
sampling in medial tumours. Nodal stage was subdivided into three
groups: stage 1, no node involvement; stage 2, three nodes or fewer
with metastatic involvement; and stage 3 four or more nodes with
metastatic involvement. Patients in whom lymph node sampling was
not performed were excluded from analysis oflymph node stage.
The diagnostic mammograms were reviewed by a radiologist
who knew that the patient had a grade 3 carcinoma but was
unaware of any other pathological data. Abnormalities were clas-
sified as masses, linear/branching calcification or punctate/gran-
ularcalcification. The size and nodal stage ofthe invasive tumours
in the different groups were compared. The significance of differ-
ences between groups was established using the chi-square,
Fisher's exact and Mann-Whitney U-tests.
RESULTS
The pathology slides of 61 screen-detected grade 3 cancers were
available for review. The mean histological invasive size was 16.9
mm. Eighty-two percent of the cancers were ductal carcinomas
of no special type. Size and nodal status were unavailable in one
case because the tumour was locally advanced and the patient
received non-operative therapy. Nodal status was not available in
two other cases.
Thirteen (21%) tumours had no associated DCIS, 15 (25%) had
DCIS confined to within the invasive component (minimal DCIS)
and 33 (54%) had DCIS surrounding the invasive tumour. Ninety-
five percent of associated DCIS were of high nuclear grade, 2%
were of intermediate nuclear grade and 2% of low nuclear grade.
The invasive histological sizes and nodal characteristics are shown
in Table 1. Grade 3 tumours with either no associated DCIS or
DCIS only within the invasive component were significantly
larger in size than tumours with surrounding DCIS (P<0.02) and
were less likely to be under or equal to 10 mm in size (0% or 13%
vs 30% respectively, P<0.02).
There was a trend for tumours with surrounding DCIS to have
less frequent nodal involvement than the other two groups, but
this did not reach statistical significance (28% vs 42% and 43%
respectively). No mammographic calcification was seen in the no
DCIS group; however it was seen in 40% of the minimal DCIS
group and 58% ofthe surrounding DCIS group.
Fourteen (23%) tumours showed linear/branching calcification,
11(18%) tumours showed punctate/granular calcification and 35
(58%) tumours showed masses without calcification on mammo-
graphy (54% ill-defined masses, 37% spiculate masses, 8% archi-
tectural distortions, 5% developing density and 5% asymmetric
density). One tumour was detected clinically by the radiographer
below the inframammary fold and was therefore not imaged by
mammography. The histological size and lymph node stage char-
acteristics, according to mammographic appearance, are shown in
Table 2. Grade 3 tumours showing mammographic calcification
were not significantly smaller overall than non-calcific tumours.
Calcific tumours were, however, more likely to be less than or
equal to 10 mm in size than non-calcific tumours (32% vs 11%
respectively, P<0.05). This was because of the high frequency of
tumours less than or equal to 10 mm in size in the linear/branching
calcification group. This group represents only 23% of all the
tumours but contained 50% of all such small tumours. 43% of
tumours showing linear/branching calcification were less than or
equal to 10 mm in size compared with 13% in those tumours not
showing linear/branching calcification mammographically.
Tumours showing calcification without a mass also appear to be
a group with particularly good prognostic features, with a mean
size of 13 mm, 33% being 10 mm or less in size and only 17%
being node positive (Table 2).
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DISCUSSION
Mammographic screening tends to detect a higher proportion of
low-grade invasive tumours than is seen in symptomatic practice
(Cowan et al, 1991; Klemi et al, 1992); this is especially true in the
prevalent mammographic screening round (Anderson et al, 1986).
DCIS is also found more frequently at mammographic screening
than in symptomatic series. DCIS accounts for 15-25% of screen-
detected carcinomas, compared with 5% in symptomatic breast
cancer (Smart et al, 1978; Rosner et al, 1980; Bearhrs et al, 1979;
Anderson et al, 1988). This has led to criticism of mammographic
screening because a proportion of women with DCIS would not
develop invasive disease if the lesion was left in situ. However,
DCIS found at mammographic screening is more likely to be ofthe
high-grade comedo type than symptomatic DCIS (Bellamy et al,
1993; Evans et al, 1994b) and therefore has a significantly higher
invasive potential (Ketcham and Moffat 1990).
There is a very close correlation between the grade of DCIS
and the grade of infiltrating carcinoma arising from it, well-
differentiated DCIS usually being associated with grade 1 invasive
tumours, intermediate-grade DCIS usually being associated with
grade 2 invasive tumours and poorly differentiated DCIS being
equally associated with grade 2 and grade 3 invasive tumours.
The type of DCIS associated with an invasive tumour was also
shown by Lampejo et al (1994) to correlate with both disease-free
survival and overall survival.
Studies on the radiological appearance of DCIS subtypes have
shown that mammography has a high sensitivity in the detection of
high-grade DCIS owing to the high frequency of visible calcifica-
tion ofintraductal necrotic debris; however, this technique is much
less sensitive in demonstrating the presence of low-grade DCIS
(Holland et al, 1990, Evans et al, 1994a). These findings suggest a
correlation between mammographically visible linear/branching
calcification and high-grade invasive carcinoma. A previous study
has shown that linear/branching calcification is seen on 19% and
any tumour-associated calcification is seen on 41% of mammo-
grams of grade 3 screen-detected invasive cancers. The presence
of linear/branching calcification and all tumour-associated calcifi-
cation has also been shown to correlate with high histological
grade in invasive screen-detected cancer (De Nunzio et al, 1996).
Calcification is therefore a useful feature in the identification of
high-grade invasive carcinoma, especially as spiculation is often
absent in these tumours (De Nunzio et al, 1996).
Tabar et al (1992a, b) have stressed the importance of finding
small, high-grade cancers at screening mammography. Data from
the two-counties screening trial has shown that grade 3 tumours
under 10 mm in size are associated with an excellent prognosis
that is not significantly worse than the prognosis of small lower
grade tumours. It is therefore vital that grade 3 tumours be detected
while small, otherwise they will occur later as interval cancers or
at subsequent screens at larger sizes and with a very poor prog-
nosis (Tabar et al, 1992a). The detection of small high-grade inva-
sive tumours may therefore be important in the reduction in breast
cancer mortality achieved by mammographic screening.
We have shown that surrounding DCIS is common in grade 3 carci-
nomas and thatthis enables mammographic detection at a smaller size
than grade 3 tumours without surrounding DCIS. Grade 3 tumours
with surrounding DCIS are more often 10 mm or less in size. There is
a non-significant trend fortumours with surrounding DCIS to be node
negative compared with grade 3 tumours without surrounding DCIS.
Our finding that tumours with mammographic calcification are more
frequently 10 mm or less in size than tumours without mammo-
graphic calcification confirms the suggestion that early detection is
aided by the presence ofcalcification in DCIS surrounding the inva-
sive tumour. Tumours with linear/branching type calcification on
mammography appear to be a subgroup with particularly good size
characteristics, with almost halfbeing 10 mm or less in size.
In conclusion, we have found that the presence of surrounding
DCIS enables earlier detection of grade 3 invasive carcinomas
because of the presence of mammographically visible calcification.
Detection ofcalcification suggestive ofDCIS shouldthereforeremain
an important part ofany mammographic screening programme.
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